How many drugs treat Tenosynovial giant cell tumor?

Drug Landscape tracks 1 marketed treatments for Tenosynovial giant cell tumor (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/tenosynovial-giant-cell-tumor.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Tenosynovial giant cell tumor — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tenosynovial giant cell tumor (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Tenosynovial giant cell tumor, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
TURALIO™	TURALIO™	Daiichi Sankyo		AP2-associated protein kinase 1, Aurora kinase B, Cyclin-dependent kinase 19

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Daiichi Sankyo · 1 drug in Tenosynovial giant cell tumor

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Tenosynovial giant cell tumor:

Cite this brief

Drug Landscape (2026). Tenosynovial giant cell tumor — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/tenosynovial-giant-cell-tumor. Accessed 2026-06-10.

Tenosynovial giant cell tumor full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing